A prime/boost strategy using DNA/fowlpox recombinants expressing the genetically attenuated E6 protein as a putative vaccine against HPV-16-associated cancers

BACKGROUND: Considering the high number of new cases of cervical cancer each year that are caused by human papilloma viruses (HPVs), the development of an effective vaccine for prevention and therapy of HPV-associated cancers, and in particular against the high-risk HPV-16 genotype, remains a priori...

Descripción completa

Detalles Bibliográficos
Autores principales: Bissa, Massimiliano, Illiano, Elena, Pacchioni, Sole, Paolini, Francesca, Zanotto, Carlo, De Giuli Morghen, Carlo, Massa, Silvia, Franconi, Rosella, Radaelli, Antonia, Venuti, Aldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351974/
https://www.ncbi.nlm.nih.gov/pubmed/25763880
http://dx.doi.org/10.1186/s12967-015-0437-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351974/
https://www.ncbi.nlm.nih.gov/pubmed/25763880
http://dx.doi.org/10.1186/s12967-015-0437-9

Ejemplares similares